Sponsors

Become a Sponsor

The Colon Cancer Alliance (CCA) thanks the following sponsors for their generous support in furthering our mission to end the suffering caused by colon cancer. Please contact Andrew Spiegel, CEO if you would like to discuss becoming a sponsor to help us increase screening rates and survivorship by providing support, education, research and advocacy.

Special Thanks to Our Sponsors

	The American Gastroenterological Association is the trust voice of the GI community. Founded in 1897, the AGA has grown to include 17,000 members from around the globe who are involved in all aspects of the science, practice and advancement of gastroenterology. The AGA Institute administers the practice, research and educational programs of the organization.
	The American Society of Colon and Rectal Surgeons is the premier society for colon and rectal surgeons and other surgeons dedicated to advancing and promoting the science and practice of the treatment of patients with diseases and disorders affecting the colon, rectum and anus.
	Amgen is a leading human therapeutics company in the biotechnology industry. For more than 25 years, the company has tapped the power of scientific discovery and innovation to advance the practice of medicine. Amgen strives to serve patients by transforming the promise of science and biotechnology into therapies that have the power to restore health or even save lives.
	The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG with annual sales of EUR 17.2 billion (2011), is one of the world’s leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer HealthCare’s aim is to discover, develop, manufacture and market products that will improve human and animal health worldwide.
	Biotechnology Industry Organization (BIO) is the world's largest biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. Our mission is to be the champion of biotechnology and the advocate for our member organizations—both large and small.
	Boston Scientific is a leading innovator of medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 30 years, Boston Scientific advances science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com.
	Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to extend and enhance human life by providing the highest-quality biopharmaceutical products. They are focused on both finding innovative medicines to combat serious diseases and on getting them to patients faster and more efficiently.
	The Boehringer Ingelheim group*, the makers of Dulcolax, is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates and more than 44,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel medications of high therapeutic value for human and veterinary medicine. *Dulcolax® products are marketed and distributed by Boehringer Ingelheim Pharmaceuticals, Inc.
	Ethicon Endo-Surgery, Inc. (EES) works with clinicians from around the world to develop products that advance minimally invasive colorectal surgery. The goal is to provide better care for patients so they can return to their lives sooner, with less trauma and fewer complications.
	GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. GE Healthcare's broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases and other conditions earlier. Their vision for the future is to enable a new "early health" model of care focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention.
	Genentech BioOncology is an industry leader in researching the molecular basis of cancer with a long-standing commitment to fundamentally transforming the way cancer is treated. Genentech believes that studying the biological pathways involved in cancer development, progression and metastasis holds the key to identifying promising molecular targets. Genentech BioOncology is focused on both the basic biology of cancer and its application to therapeutics in oncology.
	Genomic Health is a life science company founded in August of 2000 and located in Redwood City, California. It is committed to improving the quality of cancer treatment decisions through the research, development and commercialization of genomic-based clinical laboratory services. To that end, the company conducts sophisticated genomic research to develop new tools for diagnosis that provide individualized information on response to certain types of therapy, as well as the likelihood of disease recurrence. This is done through examining the behavior of multiple genes—a process known as genomic analysis— to provide patients and healthcare professionals with a better understanding of what is happening inside the patient’s tumor. These diagnostic technologies generate information that healthcare providers and patients can use in making treatment decisions.
	Driven to enrich and delight the world through foods and brands that matter, Kellogg Company (NYSE: K) is the world’s leading producer of cereal and a leading producer of snacks and frozen foods. Every day, our well-loved brands - produced in 17 countries and marketed in more than 180 countries - nourish families so they can flourish and thrive. With 2011 sales of more than $13 billion, these brands include Cheez-It®, Coco Pops®, Corn Flakes®, Eggo®, Frosted Flakes®, Kashi®, Keebler®, Kellogg’s®, Mini-Wheats®, Pop-Tarts®, Rice Krispies®, Special K®, and many more.
	The Medical Imaging & Technology Alliance (MITA), a division of the National Electrical Manufacturers Association (NEMA), is the collective voice of medical imaging equipment manufacturers, innovators, and product developers. It represents companies whose sales comprise more than 90 percent of the global market for medical imaging technology.
	Morphotek is committed to developing novel classes of biological-based products to treat cancer, inflammatory diseases and infectious diseases. The company believes that mAbs (the fastest growing segment of the biopharmaceutical market), as well as other target-specific biological-based therapies, hold the greatest promise to specifically treat and eradicate human disease. Morphotek’s mission is to develop superior mAbs and biological therapies optimized for pharmacological activity using our suite of proprietary technologies. Morphotek will continue to achieve these goals by employing and collaborating with the best talent in industry and academia, and empowering them to achieve extraordinary results.
	Roche is an innovator of products and services for the early detection, prevention, diagnosis and treatment of diseases. They contribute on a broad range of fronts to improving people's health and quality of life. Roche's mission is to create added value in healthcare by focusing on diagnostics and pharmaceuticals.
	Sanofi-aventis is a leading global pharmaceutical company that discovers, develops, produces and markets innovative therapies that enhance people's lives. Their extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders and vaccines.
	Salix is committed to being the leading U.S. specialty pharmaceutical company licensing, developing and marketing innovative products to healthcare professionals to prevent or treat gastrointestinal disorders in patients while providing rewarding opportunities for our employees and creating exceptional value for our stockholders.
	Sirtex Medical Inc is a leading developer of targeted and innovative cancer therapies. Selective Internal Radiation Therapy (SIRT), also known as radioembolization, is a targeted treatment that delivers millions of radioactive beads called SIR-Spheres® microspheres to treat metastatic colorectal cancer. SIRT is an outpatient treatment performed by an interventional radiologist. In clinical studies, SIR-Spheres has been used with modern systemic chemotherapy or as a monotherpay. SIR-Spheres microspheres is a the only FDA approved microsphere for the treatment of metastatic colorectal liver tumors. For more information go to www.sirtex.com.
	Spectrum Pharmaceuticals is a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology. The Company’s strategy is comprised of acquiring, developing and commercializing a broad and diverse pipeline of late-stage clinical and commercial products.  The Company markets two oncology drugs, FUSILEV and ZEVALIN and has two drugs, apaziquone and belinostat, in late stage development along with a diversified pipeline of novel drug candidates.  The Company has assembled an integrated in-house scientific team, including clinical development, medical research, regulatory affairs, biostatistics and data management, formulation development, and has established a commercial infrastructure for the marketing of its drug products.  The Company also leverages the expertise of its worldwide partners to assist in the execution of its strategy.  For more information, please visit www.sppirx.com.

Return